Uncategorized

Anne Li                    2/9/18   An experimental hormone therapy delays the spread of prostate cancer that has stopped responding to standard treatment, according to new clinical trial results. The drug, called apalutamide, reduced the…

Anne Li                        2/9/18   Treatment with an investigational androgen receptor inhibitor significantly delayed the development of metastasis in patients with prostate cancer that had become resistant to standard androgen-deprivation therapy. The…

Anne Li                                           2/9/18   New research from The Scripps Research Institute (TSRI) may give scientists a chance to target tumors before they…

Anne Li                                        2/9/18   Long after cancer treatment ends, many continue to deal with one particular symptom that refuses to go away: fatigue.…